Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2009

Feb 27, 2009

34519_dirs_2009-02-27_31ff2c90-b1eb-4723-b4d4-5ccf5cc7121f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2009-02-27

Reporting Person: BRIGHAM MICHAEL F (Director, President & CEO)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2009-02-27 Common Stock, par value $0.10 per share P 51000 $1.3125 Acquired 153870 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2009-02-27 Incentive stock options (right to buy) $1.3125 X 51000 Disposed 2009-02-27 common stock (51000) Direct

Footnotes

F1: Exercisable as to one-third on March 1, 2000, one-third March 1, 2001 and the remaining one-third on March 1, 2002.